# Qingkong Jinxin Blue Microbiology Fund

> Qingkong Jinxin Blue Microbiology Fund is a VC fund backing Robotics and Electronics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jul 2025
- Lead investor: 0%
- Last updated: Aug 2026

Qingkong Jinxin Blue Microbiology Fund is a VC fund focused on Robotics and Electronics. Qingkong Jinxin Blue Microbiology Fund

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Robotics | 1 | 33% |
| Electronics | 1 | 33% |
| Health Care | 1 | 33% |
| Biotechnology | 1 | 33% |
| Manufacturing | 1 | 33% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Robot Era | Robot era is an emerging technology business creates embodied intelligence and generic humanoid robot technologies and products. Xingdong Era is committed to the development of universal humanoid robots that can adapt to a wide range of fields, multiple scenarios, and high intelligence, striving to realize the beautiful vision of intelligent robotsentering thousands of households and integrating into the lights of thousands of homes. | $69.7M | Series A | Jul 07, 2025 |  |
| Inspur Health | Inspur Health provides platform for storing medical data. | $14.3M | Series A | Feb 18, 2020 |  |
| Zhiyi Pharmaceutics | Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and theinnovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains. | $7.1M | Series A | Sep 05, 2018 |  |

3 of 3 investments shown.

## Co-investors
- [CDH Investments](https://shizune.co/investors/profile/cdh-investments) — VC Fund, 2 deals together
- [China Galaxy Securities](https://shizune.co/investors/profile/china-galaxy-securities) — VC Fund, 1 deal together
- [Crystal Stream Capital](https://shizune.co/investors/profile/crystal-stream) — VC Fund, 1 deal together
- Fengli Intelligent — VC Fund, 1 deal together
- [Haier Capital](https://shizune.co/investors/profile/haier-capital) — VC Fund, 1 deal together
- [Houxue Capital](https://shizune.co/investors/profile/houxue-capital) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Qingkong Jinxin Blue Microbiology Fund invest in?

Qingkong Jinxin Blue Microbiology Fund invests primarily in Robotics, Electronics and Health Care startups, most often at Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Qingkong Jinxin Blue Microbiology Fund last invest?

The most recent investment recorded for Qingkong Jinxin Blue Microbiology Fund closed in Jul 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co